Dentifrice With Innovative Remineralizing Technology: a Randomized Clinical Study (REFIX)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04730908 |
|
Recruitment Status :
Recruiting
First Posted : January 29, 2021
Last Update Posted : January 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Fluoride Biomarkers in the Oral Mouth After Brushing Teeth With the Experimental Dentifrice Bioavailability of Fluoride in the Oral Mouth | Other: DENTIFRICE | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 20 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Intervention Model Description: | Crossover study testing 4 dental gel for brushing teeth. the brushing period of use :7 days, 3 times daily with wahs-out periods of one week. |
| Masking: | Triple (Participant, Care Provider, Investigator) |
| Masking Description: | the products are coded with different color in the label. |
| Primary Purpose: | Prevention |
| Official Title: | Dentifrice With Innovative Remineralizing Technology: a Randomized Clinical Study |
| Actual Study Start Date : | February 3, 2020 |
| Estimated Primary Completion Date : | April 12, 2021 |
| Estimated Study Completion Date : | September 12, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Placebo Comparator: G0 - placebo
Dental gel without fluoride in the composition
|
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE |
|
Sham Comparator: G1: Daily Regenerator Dentalclean Neutro (RDCN)
1450 ppm F- of sodium fluoride and tetrasodium pyrophosphate (Refix technology). NEUTRAL pH
|
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE |
|
Active Comparator: G2: Sensodyne Repair & Protect (SRP)
1426 ppm of sodium fluoride and calcium sodium phosphosilicate 5% (NOVAMIN technology).
|
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE |
|
Experimental: G3: Daily Regenerator Dentalclean Acid (RDCA)
1450 ppm F- of sodium fluoride and tetrasodium pyrophosphate (Refix technology). ACIDIC FORMULA
|
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE |
|
Active Comparator: G4: Colgate Total Daily Repair (CTDR)
1450 ppm F- of as sodium fluoride, 0.30% triclosan, arginine, tetrasodium pyrophosphate.
|
Other: DENTIFRICE
GEL -DENTIFRICE FOR BRUSHING TEETH
Other Name: TOOTHPASTE |
- FLUORIDE IN SALIVA [ Time Frame: 12 hours ]Concentration of fluoride in saliva after brushing teeth
- FLUORIDE IN DENTAL PLAQUE [ Time Frame: 12 hours ]Concentration of fluoride in dental biofilm after brushing teeth
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- The eligibility criteria were people over 18 years old, without systemic commitment and living in the city of João Pessoa-Paraíba, without water fluoridation (< 0.1 μg/mL F).
Exclusion Criteria:
- Individuals were excluded if they used drugs that interfere with biofilm formation and salivary flow or fluoride products (> 5000 ppm) in the last 4 weeks, used orthodontic appliances, or had cavity lesions, periodontal disease, and/or tooth sensitivity.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04730908
| Brazil | |
| Federal University of Paraíba | Recruiting |
| João Pessoa, Paraíba, Brazil | |
| Contact: Fábio C Sampaio, Doctor +55 83 32167795 fcsampa@gmail.com | |
| Responsible Party: | Fabio Correia Sampaio, Professor, Federal University of Paraíba |
| ClinicalTrials.gov Identifier: | NCT04730908 |
| Other Study ID Numbers: |
REFIX-UFPB |
| First Posted: | January 29, 2021 Key Record Dates |
| Last Update Posted: | January 29, 2021 |
| Last Verified: | January 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

